UBS AG - PHARMATHENE INC ownership

PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 38 filers reported holding PHARMATHENE INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS AG ownership history of PHARMATHENE INC
ValueSharesWeighting
Q3 2014$36,000
-54.4%
20,227
-63.8%
0.00%
Q2 2014$79,000
-26.2%
55,896
-4.7%
0.00%
Q1 2014$107,000
+25.9%
58,658
+27.4%
0.00%
Q4 2013$85,000
+4150.0%
46,049
+4504.9%
0.00%
Q3 2013$2,000
-94.1%
1,000
-95.3%
0.00%
Q2 2013$34,00021,1070.00%
Other shareholders
PHARMATHENE INC shareholders Q3 2014
NameSharesValueWeighting ↓
Northern Right Capital Management, L.P. 1,328,108$4,316,0004.41%
PERKINS CAPITAL MANAGEMENT INC 708,100$2,301,0002.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3,262,422$10,603,0002.23%
Nantahala Capital Management 3,202,045$10,407,0001.08%
TFS CAPITAL LLC 453,016$1,472,0000.39%
Teza Capital Management LLC 34,000$110,0000.15%
Acrospire Investment Management LLC 58,081$189,0000.08%
ALPINE WOODS CAPITAL INVESTORS, LLC 414,816$1,348,0000.07%
OXFORD ASSET MANAGEMENT LLP 526,066$1,710,0000.06%
TWO SIGMA SECURITIES, LLC 55,733$181,0000.06%
View complete list of PHARMATHENE INC shareholders